Professor Windisch draws on over 20 years of experience to explain why and how we should use home NIV in COPD, with a particular focus on patient selection and quality of life.
Home NIV in stable COPD: how & why
Watch this symposium to learn why and how we should use home NIV in COPD based on a review of clinical evidence.
The symposium was sponsored by ResMed.
The symposium was sponsored by ResMed.
This is a secured video. To access it for the first time you must fill-in your email address above. Key facts
-
ResMed webinar on home non-invasive ventilation for COPD
-
With Prof. Wolfram Windisch
-
Home NIV in stable COPD: how & why
Content
Speakers
Wolfram Windisch
Department of Pneumology
Cologne Merheim Hospital – Kliniken der Stadt Köln GmbH
University of Witten / Herdecke, Germany
Cologne Merheim Hospital – Kliniken der Stadt Köln GmbH
University of Witten / Herdecke, Germany
Other related videos
Watch now
04/12/2019
Stefanie Werther discusses practical challenges, such as defining pathways and training staff, while also highlighting the positive potential of COPD telemonitoring.
04/12/2019
Michael Dreher presents the outcome of the HomeVent registry on the prevalence of hypercapnia in COPD stage 3 and 4 and the upcoming HomeVent Connect study. One to watch if your focus is COPD, NIV and...
Looking for more information?
COPD Research at ResMed
ResMed supports multiple global trials that are investigating outcomes in COPD patients treated with non-invasive ventilation (NIV).
Learn more
[Research] Non-invasive ventilation for COPD patients
Treatment of COPD with noninvasive ventilation (NIV) has been shown to be effective in treating acute exacerbations of COPD
Learn more